Our findings support the hypothesis that overexpression of SIRT3 elevates FOXO3a/CDT1 axis, thus contributing to inhibited lung cancer cell viability, proliferation, and invasion as well as enhanced cell apoptosis and sensitivity of lung cancer cells to cisplatin (Figure 7). This evidence concerns the gene FOXO3 and lung cancer.